Загрузка...
A novel target for combination immunotherapy in pancreatic cancer: IL-1β mediates immunosuppression in the tumour microenvironment
Immune checkpoint blockade (ICB) has demonstrated efficacy in multiple cancers, offering the potential of long-term disease control not achievable with cytotoxic or targeted therapies. However, the field has not yet achieved the crucial next steps — the expansion of the response rate and achievement...
Сохранить в:
| Опубликовано в: : | Br J Cancer |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8144204/ https://ncbi.nlm.nih.gov/pubmed/33758330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-021-01303-2 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|